Open Study Summaries – Prostate Cancer

Please consult with your physician or contact the cancer research office at 757-388-2840.

Prostate Cancer

RTOG 0924 – Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial (NRG)

{{moduleTitle}}